ARCHIVES

FDA Approves NDA For Mylan’s Paclitaxel For Ovarian And Breast Cancer Treatment.

This article is from The Cancer Letter archive.

Vol. 27 No. 30 | July 27, 2001

Download PDF Visit The Full Archive

Related Articles

DCE Board Approve Concepts For Contract Recompetitions

November 23, 1984

National Coalition for Cancer Research Formed To Support Reauthorization, l Research Budgets

April 19, 1985

NCI Seeks Health Care Provider Groups To Form Cancer Control Research Network

September 12, 1997

NCI Workshop Summary “Incomplete,” Kopans Writes In Letter

April 16, 1993

In Brief: DCE Board Nixes NIH Intramural Postdoctural Program Magazines Rapped For Cigarette Ads

July 13, 1984

New England Medical Center Discloses Case Of Two Overdoses

April 28, 1995